Suchergebnisse - "Trastuzumab"

PubPharm (16.244)

1

A Multifunctional Bimetallic Nanoplatform for Synergic Local Hyperthermia and Chemotherapy Targeting HER2-Positive Breast Cancer

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Zhao, L. | Chang, F. | Tong, Y. | +5

2

Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for Breast Cancers

enthalten in: Monoclonal antibodies in immunodiagnosis and immunotherapy | 2024

von Kaneko, M. | Suzuki, H. | Kato, Y.

ErratumIn: Monoclon Antib Immunodiagn Immunother. 2024 Apr 16;:. - PMID 38625004

3

Noncoding RNA-associated competing endogenous RNA networks in trastuzumab-induced cardiotoxicity

enthalten in: Non-coding RNA research | 2024

von Xie, S. | Zhou, N. | Su, N. | +6

4

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

enthalten in: Translational oncology | 2024

von Velázquez-Vega, L. | Rivera-Robles, M. | Sánchez-Álvarez, A. | +8

5

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

6

Antibody-Drug Conjugates in Triple Negative Breast Cancer

enthalten in: Clinical breast cancer | 2024

von Keskinkilic, M. | Sacks, R.

7

Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

enthalten in: Anticancer research | 2024

von Sato, M. | Han, Q. | Mori, R. | +7

8

Fe3O4-Cy5.5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer

enthalten in: Biomedical materials (Bristol, England) | 2024

von Yin, Q. | Gao, X. | Zhang, H. | +5

9

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea : a real-world post-marketing surveillance study

enthalten in: Expert opinion on biological therapy | 2024

von Park, M. | Seo, J. | Park, J. | +18

10

Incidence of antibody-drug conjugate-related fatigue in patients with breast cancer : A systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Zhang, H. | Shen, G. | Yang, P. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1625]